# Treatment for Classical Hodgkin Lymphoma in Children and Adolescents

> **NCT02797717** · NA · RECRUITING · sponsor: **GALIA AVRAHAMI** · enrollment: 2200 (estimated)

## Conditions studied

- Classical Hodgkins Lymphoma in Children and Adolescents.

## Interventions

- **RADIATION:** Radiotherapy:
- **DRUG:** Vincristine
- **DRUG:** Etoposide
- **DRUG:** Prednisone
- **DRUG:** Doxorubicin
- **DRUG:** Dacarbazine
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT02797717
- **Lead sponsor:** GALIA AVRAHAMI
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-11
- **Primary completion:** 2022-12
- **Final completion:** 2027-12
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2016-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02797717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02797717, "Treatment for Classical Hodgkin Lymphoma in Children and Adolescents". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02797717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*